Dr. Robert Malone's letter goes through FDA's Pfizer authorization of Comirnaty and what it means

Reading Dr. Robert Malone's Letter About The FDA's Approval Of The Pfizer "Vaccine" and what it means.
https://www.rwmalonemd.com/news

Dr. Robert Malone's letter goes through FDA's Pfizer authorization (Comirnaty):

Key points to consider and discuss.

General talking points
• Why mandates if herd immunity isn't possible?
• What happens 8 months after boosters?
• What's the plan for the next variant?
• Why we're messing with vaccine injury liability if the vaccines are safe and effective?

There are now TWO LEGALLY distinct (Pfizer vs BionTech), but otherwise identical products,
based on two FDA letters, as well as a press release. The analysis of these FDA products
below is preliminary and subject to change.
Links to available PDF's and Required Studies

Letter to Pfizer
https://www.fda.gov/media/150386/download

Letter to BioNTech (COMIRNATY)
https://www.fda.gov/media/151710/download

Press Release
https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine

Pregnacy Study
https://mothertobaby.org/ongoingstudy/covid19-vaccines/

Deferred pediatric Study C4591007 to evaluate the safety and effectiveness of
COMIRNATY in infants and children 6 months to <12 years of age.
https://clinicaltrials.gov/ct2/show/NCT04816643

Deferred pediatric Study C4591001 to evaluate the safety and effectiveness of
COMIRNATY in children 12 years through 15 years of age.
https://clinicaltrials.gov/ct2/show/NCT04816643

Study C4591031 substudy to prospectively assess the incidence of
subclinical myocarditis following administration of a third dose of
COMIRNATY in a subset of participants 16 to 30 years of age.
https://clinicaltrials.gov/ct2/show/NCT04955626?term=C4591031&draw=2&rank=1

Study C4591014, entitled “Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California.”
https://clinicaltrials.gov/ct2/show/NCT04848584?term=C4591014&draw=2&rank=1